Baidu
map

大督查在行动:长沙医联体全覆盖 小病首诊在社区

2017-07-21 佚名 央视网

国务院第四次大督查,十二督察组、十七督察组分别到长沙,西安,督查医联体建设及异地就医结算系统。

7月18日,国务院第四次大督查第十二督察组在走访调研过程中发现,湖南长沙市探索建立医联体运行模式,让市级医院的知名医生能成为乡村诊所卫生院的骨干,基层医疗机构急重病人能够便捷地向大医院转诊,而康复期病人也能够向下一级医疗机构转诊。

34岁的陈博几天前突发重症胰腺炎住进长沙市岳麓区咸嘉湖社区医疗卫生服务中心。由于病情严重,社区医疗中心确诊之后,立即通过医联体办公室,当天就将他转诊到了一家市级三级医院。因为抢救及时,陈博现在生命体征平稳,恢复良好。

陈博说:“社区医院给我诊断出来后,就马上打电话叫120,给我开通绿色通道送我过来。”陈博之所以能够顺利转院得益于长沙市推行的医联体运行模式。

所谓医联体运行模式,是指将同一个区域内的医疗资源整合在一起,一个市级三级医院与二级医院、社区医院、村级卫生室共同组成了一个医疗联合体。

长沙市卫计委主任周敏提到:“医联体的话就是要实现一个真正的基层首诊和上下转诊,急慢分治。”

2013年,湖南长沙开始医联体试点建设,让市一级的三级医院按照区域,牵手基层医疗机构,同时市财政对基层医疗机构的硬件改造提供支持。

目前,湖南长沙市的7家三级公立医院已经全部与基层医疗机构建立了医联体。全市1083个全科医疗团队、16个名医工作站长期活跃在基层医疗机构中。

2016年长沙市乡镇卫生院、社区卫生服务中心门诊人次达到584.5万,较上年增加10.23%,差不多90%以上居民实现在社区或者乡镇机构进行首诊。

督察组成员白宇表示:“通过一系列的机制建设,实现了优质医疗的资源下沉,实现了基层医疗服务机构能力的提升,从而也带来了分级诊疗制度在基层的一个落实。那么老百姓就得到了切实的实惠,能够做到小病不出社区,不必要集中到大的三甲医院去。”

7月19日上午,国务院第四次大督查第十七督查组来到陕西西安,督查异地就医直接结算和医联体建设情况。

宝鸡市岐山县李涛的父亲患上了肿瘤,当地县医院技术设备落后无法完成后续治疗,通过省内开通的异地就医渠道,李涛的父亲实现了定期到西安一家三级甲等医院来化疗。

患者家属李涛说:“异地安置,我们在西安指定两个医院,不管什么病,来看就完了。”

李涛父亲这次化疗共花费了一万多元,由于医院实现了异地就医直接结算,李涛在为父亲办理出院手续时,个人只花了四千多元,当场就完成了费用结算。

目前,陕西省在实现省内异地就医结算的基础上,又实现了跨省异地就医结算,符合条件的人员可以实现就医医疗费用的直接结算,今后陕西还将进一步扩大异地就医结算人员范围,方便广大患者看病诊治。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2066251, encodeId=11462066251d3, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Fri Jan 05 07:39:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749150, encodeId=5eae1e4915073, content=<a href='/topic/show?id=a2c7e306196' target=_blank style='color:#2F92EE;'>#督查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73061, encryptionId=a2c7e306196, topicName=督查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af2436239757, createdName=wodejia-dayu, createdTime=Tue Apr 17 17:39:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335593, encodeId=ef9c1335593e4, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395692, encodeId=a5ef1395692e7, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224955, encodeId=60d62249555b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM7V1lG3lEERmrZh1ZAYgnIqsCAwFfLlOdXroVwBJqvTvw/0, createdBy=b2522082239, createdName=维维豆奶, createdTime=Sat Jul 22 08:08:21 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2066251, encodeId=11462066251d3, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Fri Jan 05 07:39:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749150, encodeId=5eae1e4915073, content=<a href='/topic/show?id=a2c7e306196' target=_blank style='color:#2F92EE;'>#督查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73061, encryptionId=a2c7e306196, topicName=督查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af2436239757, createdName=wodejia-dayu, createdTime=Tue Apr 17 17:39:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335593, encodeId=ef9c1335593e4, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395692, encodeId=a5ef1395692e7, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224955, encodeId=60d62249555b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM7V1lG3lEERmrZh1ZAYgnIqsCAwFfLlOdXroVwBJqvTvw/0, createdBy=b2522082239, createdName=维维豆奶, createdTime=Sat Jul 22 08:08:21 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2066251, encodeId=11462066251d3, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Fri Jan 05 07:39:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749150, encodeId=5eae1e4915073, content=<a href='/topic/show?id=a2c7e306196' target=_blank style='color:#2F92EE;'>#督查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73061, encryptionId=a2c7e306196, topicName=督查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af2436239757, createdName=wodejia-dayu, createdTime=Tue Apr 17 17:39:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335593, encodeId=ef9c1335593e4, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395692, encodeId=a5ef1395692e7, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224955, encodeId=60d62249555b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM7V1lG3lEERmrZh1ZAYgnIqsCAwFfLlOdXroVwBJqvTvw/0, createdBy=b2522082239, createdName=维维豆奶, createdTime=Sat Jul 22 08:08:21 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2066251, encodeId=11462066251d3, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Fri Jan 05 07:39:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749150, encodeId=5eae1e4915073, content=<a href='/topic/show?id=a2c7e306196' target=_blank style='color:#2F92EE;'>#督查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73061, encryptionId=a2c7e306196, topicName=督查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af2436239757, createdName=wodejia-dayu, createdTime=Tue Apr 17 17:39:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335593, encodeId=ef9c1335593e4, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395692, encodeId=a5ef1395692e7, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224955, encodeId=60d62249555b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM7V1lG3lEERmrZh1ZAYgnIqsCAwFfLlOdXroVwBJqvTvw/0, createdBy=b2522082239, createdName=维维豆奶, createdTime=Sat Jul 22 08:08:21 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2066251, encodeId=11462066251d3, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Fri Jan 05 07:39:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749150, encodeId=5eae1e4915073, content=<a href='/topic/show?id=a2c7e306196' target=_blank style='color:#2F92EE;'>#督查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73061, encryptionId=a2c7e306196, topicName=督查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af2436239757, createdName=wodejia-dayu, createdTime=Tue Apr 17 17:39:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335593, encodeId=ef9c1335593e4, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395692, encodeId=a5ef1395692e7, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Jul 23 05:39:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224955, encodeId=60d62249555b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM7V1lG3lEERmrZh1ZAYgnIqsCAwFfLlOdXroVwBJqvTvw/0, createdBy=b2522082239, createdName=维维豆奶, createdTime=Sat Jul 22 08:08:21 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-22 维维豆奶

    学习了

    0

Baidu
map
Baidu
map
Baidu
map